HomeComparePSTTF vs QSR

PSTTF vs QSR: Dividend Comparison 2026

PSTTF yields 1379.31% · QSR yields 3.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PSTTF wins by $327926178.91M in total portfolio value
10 years
PSTTF
PSTTF
● Live price
1379.31%
Share price
$0.15
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$327926178.94M
Annual income
$286,995,341,463,684.70
Full PSTTF calculator →
QSR
QSR
● Live price
3.40%
Share price
$73.76
Annual div
$2.51
5Y div CAGR
-0.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.7K
Annual income
$387.88
Full QSR calculator →

Portfolio growth — PSTTF vs QSR

📍 PSTTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPSTTFQSR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PSTTF + QSR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PSTTF pays
QSR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PSTTF
Annual income on $10K today (after 15% tax)
$117,241.38/yr
After 10yr DRIP, annual income (after tax)
$243,946,040,244,131.97/yr
QSR
Annual income on $10K today (after 15% tax)
$289.25/yr
After 10yr DRIP, annual income (after tax)
$329.70/yr
At 15% tax rate, PSTTF beats the other by $243,946,040,243,802.28/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PSTTF + QSR for your $10,000?

PSTTF: 50%QSR: 50%
100% QSR50/50100% PSTTF
Portfolio after 10yr
$163963089.48M
Annual income
$143,497,670,732,036.28/yr
Blended yield
87.52%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on QSR right now

PSTTF
No analyst data
QSR
Analyst Ratings
27
Buy
15
Hold
2
Sell
Consensus: Buy
Price Target
$81.57
+10.6% upside vs current
Range: $71.00 — $90.00
Altman Z
1.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PSTTF buys
0
QSR buys
0
No recent congressional trades found for PSTTF or QSR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPSTTFQSR
Forward yield1379.31%3.40%
Annual dividend / share$2.00$2.51
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-0.8%
Portfolio after 10y$327926178.94M$24.7K
Annual income after 10y$286,995,341,463,684.70$387.88
Total dividends collected$324920394.51M$3.7K
Payment frequencyquarterlyquarterly
SectorStockStock

Year-by-year: PSTTF vs QSR ($10,000, DRIP)

YearPSTTF PortfolioPSTTF Income/yrQSR PortfolioQSR Income/yrGap
1← crossover$148,631$137,931.03$11,038$337.57+$137.6KPSTTF
2$2,075,001$1,915,965.64$12,156$345.43+$2.06MPSTTF
3$27,218,680$24,998,428.97$13,359$352.69+$27.21MPSTTF
4$335,586,754$306,462,766.83$14,654$359.36+$335.57MPSTTF
5$3,890,354,077$3,531,276,249.42$16,045$365.45+$3890.34MPSTTF
6$42,421,557,343$38,258,878,480.81$17,539$370.97+$42421.54MPSTTF
7$435,284,512,667$389,893,446,310.20$19,143$375.96+$435284.49MPSTTF
8$4,204,696,744,549$3,738,942,315,995.26$20,863$380.42+$4204696.72MPSTTF
9$38,253,119,134,080$33,754,093,617,412.28$22,708$384.39+$38253119.11MPSTTF
10$327,926,178,937,150$286,995,341,463,684.70$24,685$387.88+$327926178.91MPSTTF

PSTTF vs QSR: Complete Analysis 2026

PSTTFStock

Prescient Therapeutics Limited, a clinical stage oncology company, develops novel drugs for the treatment of various cancers in Australia. Its lead drug candidate is PTX-200, which is in Phase 2a clinical trial for HER2-negative breast cancer, Phase IB/2 clinical trial in relapsed and refractory AML, and Phase 1b in recurrent or persistent platinum-resistant ovarian cancer; and PTX-100, a RhoA inhibitor, for hematological and solid malignancies that focuses on cancers with Ras and RhoA mutations. It has a strategic collaboration with The University of Texas MD Anderson Cancer Center to develop blood cancer binder for OmniCAR. The company was formerly known as Virax Holdings Limited and changed its name to Prescient Therapeutics Limited in December 2014. Prescient Therapeutics Limited was incorporated in 1986 and is based in Melbourne, Australia.

Full PSTTF Calculator →

QSRStock

Restaurant Brands International Inc. operates as quick service restaurant company in Canada and internationally. It operates through four segments: Tim Hortons (TH), Burger King (BK), Popeyes Louisiana Kitchen (PLK), and Firehouse Subs (FHS). The company owns and franchises TH chain of donut/coffee/tea restaurants that offer blend coffee, tea, and espresso-based hot and cold specialty drinks; and fresh baked goods, including donuts, Timbits, bagels, muffins, cookies and pastries, grilled paninis, classic sandwiches, wraps, soups, and others. It is also involved in owning and franchising BK, a fast food hamburger restaurant chain, which offers flame-grilled hamburgers, chicken and other specialty sandwiches, french fries, soft drinks, and other food items; and PLK quick service restaurants that provide Louisiana style fried chicken, chicken tenders, fried shrimp and other seafood, red beans and rice, and other regional items. In addition, the company owns and franchises FHS restaurants quick service restaurants that offer subs, soft drinks, and local specialties. As of February 15, 2022, the company had approximately 29,000 restaurants in 100 countries under the Tim Hortons, Burger King, Popeyes, And Firehouse Subs brands. Restaurant Brands International Inc. was founded in 1954 and is headquartered in Toronto, Canada.

Full QSR Calculator →
📬

Get this PSTTF vs QSR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PSTTF vs SCHDPSTTF vs JEPIPSTTF vs OPSTTF vs KOPSTTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.